Pretreatment Immune Status Correlates With Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-15-0298
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2011English

Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib

Clinical Cancer Research
Cancer ResearchOncology
2010English

Association of MDM2 Expression With Shorter Progression-Free Survival and Overall Survival in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine-Based Chemotherapy

PLoS ONE
Multidisciplinary
2017English

GOLPH3 Predicts Survival of Colorectal Cancer Patients Treated With 5-Fluorouracil-Based Adjuvant Chemotherapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

JAMA Surgery
Surgery
2018English

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

Disease-Free Survival in Patients With Non-Metastatic Breast Cancer

Revista da Associacao Medica Brasileira
Medicine
2016English

Extending Survival With Chemotherapy in Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2005English

P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy